MedTrace Logo

Global Electrical Heterogeneity and Clinical Outcomes

NCT03210883 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3471

Last updated 2021-07-08

No results posted yet for this study

Summary

This retrospective multicenter cohort will validate an independent association of electrocardiographic (ECG) global electrical heterogeneity (GEH) measures with sustained ventricular tachyarrhythmias and appropriate ICD therapies in systolic heart failure patients with primary prevention ICD, and will validate and re-calibrate GEH ECG risk score for prediction of sustained ventricular tachyarrhythmias and appropriate ICD therapies in systolic heart failure patients with primary prevention ICD.

Conditions

  • Heart Failure
  • Implantable Defibrillator User
  • Ventricular Arrythmia

Sponsors & Collaborators

Principal Investigators

  • Larisa G Tereshchenko, MD, PhD · Oregon Health and Science University

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2021-07-05
Completion
2021-07-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03210883 on ClinicalTrials.gov